Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. CGA Limited
WARNING LETTER
•CGA Limited•May 31, 2019

CGA Limited – FDA Warning Letter, May 31, 2019

Record Details

The FDA issued a Warning Letter to CGA Limited following a May 27-31, 2019 inspection of their drug manufacturing facility in Laventille, Trinidad & Tobago. The inspection revealed significant violations of current good manufacturing practice (CGMP) regulations, rendering their drug products adulterated.

Key violations include: 1. **Inadequate Component Testing:** Failure to perform identity and impurity testing for incoming active pharmaceutical ingredients (API) as per USP monograph, relying instead on unvalidated supplier analysis reports. 2. **Incomplete Finished Product Testing and Stability Data:** Release of topical OTC drug products to the U.S. market without critical tests like active ingredient assay and identity testing, and lacking stability data to support assigned shelf-life. 3. **Equipment Maintenance and Cleaning Validation:** Apparent rust and peeling paint on product contact surfaces of non-dedicated equipment, and unvalidated cleaning methods. 4. **Unfit Water System:** Manufacturing drug products using an unvalidated water system not adequately monitored for microorganisms, and routinely drained, leading to insanitary conditions.

The FDA deemed the company's June 18, 2019, response to the Form FDA 483 inadequate due to insufficient detail on corrective actions, validation plans, and remediation of the water system.

Additionally, "CARIB® Germicidal Soap" is cited as an unapproved new drug. It is marketed as a consumer antiseptic but contains ingredients

Company
CGA Limited
Inspection date
May 31, 2019
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 385701ab-4a87-42f7-a043-c76315ba853a

Violation Codes8
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121.U.S.C. 355(a)21 U.S.C. 331(d)FD&C Act 501(a)(2)(B)FD&C Act 505FD&C Act 801(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for CGA Limited
  • 483 - 2019-05-31May 31, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CGA Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.